GE HealthCare receives FDA approval for AI contouring software

nl.investing.com (Dutch)

GE HealthCare received FDA approval for its AI-powered contouring software. The MIM Contour ProtégéAI+ 2.0 software assists radiotherapy teams in treatment planning by automating contouring on CT and MR images. This FDA clearance includes a plan for future updates, aiming to streamline a time-consuming step in cancer treatment planning.


With a significance score of 2.9, this news ranks in the top 13% of today's 33209 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


GE HealthCare receives FDA approval for AI contouring software | News Minimalist